f72f04ec0c25ac28…

{
  "id": "NCT00004845",
  "type": "Study",
  "data": {
    "briefSummary": "The primary specific aim of this clinical trial is to determine whether treatment with rofecoxib or naproxen for one year will slow the rate of decline of cognitive function in patients with Alzheimer's disease (AD) as measured by ADAScog.",
    "completionDate": "2001-12",
    "conditions": [
      "Alzheimer Disease"
    ],
    "enrollmentCount": null,
    "enrollmentType": null,
    "nctId": "NCT00004845",
    "phase": "PHASE2, PHASE3",
    "sponsorId": "national-institute-on-aging-nia",
    "startDate": null,
    "status": "COMPLETED",
    "studyType": "INTERVENTIONAL",
    "title": "A Multicenter Trial of Rofecoxib and Naproxen in Alzheimer's Disease",
    "url": "https://clinicaltrials.gov/study/NCT00004845"
  }
}